Related Experiment Video
Updated: Aug 25, 2025
08:56
Tissue-Engineered Graft for Circumferential Esophageal Reconstruction in Rats
Published on: February 10, 2020
7.2K
Bio-Engineered Scaffolds Derived from Decellularized Human Esophagus for Functional Organ Reconstruction
Silvia Barbon1,2,3, Andrea Biccari2,4, Elena Stocco1,2,3
1Section of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
Cells
|October 14, 2022
Summary
This study developed decellularized esophageal allografts for reconstruction, successfully removing cells and reducing immunogenicity while preserving key extracellular matrix components for potential tissue engineering applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Surgical Innovation
Background:
- Current esophageal reconstruction methods have limitations.
- Bio-engineered allografts mimicking native tissue extracellular matrix (ECM) offer a promising alternative.
- Developing acellular esophageal scaffolds is crucial for overcoming surgical challenges.
Purpose of the Study:
- To decellularize human esophagus using three protocols and evaluate scaffold properties.
- To assess the efficacy of decellularization in removing cellular components and DNA.
- To characterize the preservation of ECM components and the immunogenicity of the resulting allografts.
Main Methods:
- Comparison of three detergent-enzymatic decellularization protocols on human esophagus.
- DNA quantification, histological analysis, and proteomic profiling of decellularized tissues.
- Assessment of glycosaminoglycan and hydroxyproline content, ECM marker expression, and mechanical properties.
- Immunohistochemistry for HLA-DR expression and cytotoxicity testing for biosafety.
Main Results:
- All protocols effectively removed cells and DNA (<50 ng/mg), preserving collagen and elastin.
- Glycosaminoglycans (70-98%) and ECM markers (collagen IV, laminin) were maintained.
- Decellularization reduced immunogenicity (loss of HLA-DR) and maintained matrix integrity, though stiffness decreased.
- Scaffolds were non-cytotoxic, indicating biosafety.
Conclusions:
- Decellularized human esophageal matrices retain crucial ECM components and exhibit reduced immunogenicity.
- The evaluated methods offer potential for creating safe and effective esophageal allografts for reconstruction.
- Further in vivo studies are necessary to validate the functional capacity of these scaffolds.
